Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry.

Van Raemdonck D, Keshavjee S, Levvey B, Cherikh WS, Snell G, Erasmus M, Simon A, Glanville AR, Clark S, D'Ovidio F, Catarino P, McCurry K, Hertz MI, Venkateswaran R, Hopkins P, Inci I, Walia R, Kreisel D, Mascaro J, Dilling DF, Camp P, Mason D, Musk M, Burch M, Fisher A, Yusen RD, Stehlik J, Cypel M; International Society for Heart and Lung Transplantation.

J Heart Lung Transplant. 2019 Dec;38(12):1235-1245. doi: 10.1016/j.healun.2019.09.007.

PMID:
31777330
2.

Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines.

Crow LD, Jambusaria-Pahlajani A, Chung CL, Baran DA, Lowenstein SE, Abdelmalek M, Ahmed RL, Anadkat MJ, Arcasoy SM, Berg D, Bibee KP, Billingsley E, Black WH, Blalock TW, Bleicher M, Brennan DC, Brodland DG, Brown MR, Carroll BT, Carucci JA, Chang TW, Chaux G, Cusack CA, Dilling DF, Doyle A, Emtiazjoo AM, Ferguson NH, Fosko SW, Fox MC, Goral S, Gray AL, Griffin JR, Hachem RR, Hall SA, Hanlon AM, Hayes D Jr, Hickey GW, Holtz J, Hopkins RS, Hu J, Huang CC, Brian Jiang SI, Kapnadak SG, Kraus ES, Lease ED, Leca N, Lee JC, Leitenberger JJ, Lim MA, Longo MI, Malik SM, Mallea JM, Menter A, Myers SA, Neuburg M, Nijhawan RI, Norman DJ, Otley CC, Paek SY, Parulekar AD, Patel MJ, Patel VA, Patton TJ, Pugliano-Mauro M, Ranganna K, Ravichandran AK, Redenius R, Roll GR, Samie FH, Shin T, Singer JP, Singh P, Soon SL, Soriano T, Squires R, Stasko T, Stein JA, Taler SJ, Terrault NA, Thomas CP, Tokman S, Tomic R, Twigg AR, Wigger MA, Zeitouni NC, Arron ST.

Transpl Int. 2019 Dec;32(12):1268-1276. doi: 10.1111/tri.13520. Epub 2019 Oct 8.

PMID:
31502728
3.

Clinical outcomes and survival following lung transplantation in patients with pulmonary Langerhans cell histiocytosis.

Wajda N, Zhu Z, Jandarov R, Dilling DF, Gupta N.

Respirology. 2019 Aug 12. doi: 10.1111/resp.13671. [Epub ahead of print]

PMID:
31407478
4.

Advances in the Diagnosis and Management of Invasive Fungal Disease.

Formanek PE, Dilling DF.

Chest. 2019 Nov;156(5):834-842. doi: 10.1016/j.chest.2019.06.032. Epub 2019 Jul 24. No abstract available.

PMID:
31351046
5.

Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis.

Khawar MU, Yazdani D, Zhu Z, Jandarov R, Dilling DF, Gupta N.

J Heart Lung Transplant. 2019 Sep;38(9):949-955. doi: 10.1016/j.healun.2019.06.015. Epub 2019 Jun 21.

PMID:
31303421
6.

Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases.

Swigris JJ, Brown KK, Abdulqawi R, Buch K, Dilling DF, Koschel D, Thavarajah K, Tomic R, Inoue Y.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180075. doi: 10.1183/16000617.0075-2018. Print 2018 Dec 31. Review.

7.

The Future of Lung Transplantation.

Young KA, Dilling DF.

Chest. 2019 Mar;155(3):465-473. doi: 10.1016/j.chest.2018.08.1036. Epub 2018 Aug 29. Review.

8.

Suicidal ideation in lung transplant recipients: A case series.

Rynar LZ, Merchant MS, Dilling DF.

Clin Transplant. 2018 Jun;32(6):e13263. doi: 10.1111/ctr.13263. Epub 2018 May 12.

PMID:
29665073
9.

The 10,000-Piece Puzzle of Lymphangioleiomyomatosis.

Dilling DF.

Chest. 2018 Feb;153(2):298-299. doi: 10.1016/j.chest.2017.07.027. No abstract available.

PMID:
29406212
10.

A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.

Lu C, Lee HS, Pappas GP, Dilling DF, Burger CD, Shifren A, Veeraraghavan S, Chapman JT, Parambil J, Ruoss SJ, Young LR, Hammes SR, Kopras EJ, Roads T, Krischer JP, McCormack FX; Trial of an Aromatase Inhibitor in Lymphangioleiomyomatosis Group.

Ann Am Thorac Soc. 2017 Jun;14(6):919-928. doi: 10.1513/AnnalsATS.201610-824OC.

PMID:
28570161
11.

First Spontaneous Pneumothorax: Time for Screening High-Resolution Computed Tomographic Imaging to Look for Cystic Lung Disease?

Dilling DF.

Ann Am Thorac Soc. 2017 Jan;14(1):12-13. doi: 10.1513/AnnalsATS.201610-814ED. No abstract available.

PMID:
28035875
12.

Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in mice.

Eby JM, Barse L, Henning SW, Rabelink MJ, Klarquist J, Gilbert ER, Hammer AM, Fernandez MF, Yung N, Khan S, Miller HG, Kessler ER, Garrett-Mayer E, Dilling DF, Hoeben RC, Le Poole IC.

Cancer Immunol Immunother. 2017 Jan;66(1):63-75. doi: 10.1007/s00262-016-1920-8. Epub 2016 Oct 27.

PMID:
27787577
13.

Accuracy of chest high-resolution computed tomography in diagnosing diffuse cystic lung diseases.

Gupta N, Meraj R, Tanase D, James LE, Seyama K, Lynch DA, Akira M, Meyer CA, Ruoss SJ, Burger CD, Young LR, Almoosa KF, Veeraraghavan S, Barker AF, Lee AS, Dilling DF, Inoue Y, Cudzilo CJ, Zafar MA, McCormack FX.

Eur Respir J. 2015 Oct;46(4):1196-9. doi: 10.1183/13993003.00570-2015. Epub 2015 Jul 9. No abstract available.

14.

Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans.

Bharat A, Cunningham SA, Scott Budinger GR, Kreisel D, DeWet CJ, Gelman AE, Waites K, Crabb D, Xiao L, Bhorade S, Ambalavanan N, Dilling DF, Lowery EM, Astor T, Hachem R, Krupnick AS, DeCamp MM, Ison MG, Patel R.

Sci Transl Med. 2015 Apr 22;7(284):284re3. doi: 10.1126/scitranslmed.aaa8419.

15.

Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients.

Gagermeier JP, Rusinak JD, Lurain NS, Alex CG, Dilling DF, Wigfield CH, Love RB.

Transpl Infect Dis. 2014 Dec;16(6):941-50. doi: 10.1111/tid.12317. Epub 2014 Dec 10.

PMID:
25491023
16.

Heavy alcohol use in lung donors increases the risk for primary graft dysfunction.

Lowery EM, Kuhlmann EA, Mahoney EL, Dilling DF, Kliethermes SA, Kovacs EJ.

Alcohol Clin Exp Res. 2014 Nov;38(11):2853-61. doi: 10.1111/acer.12553.

17.

Resistance training as a preconditioning strategy for enhancing aerobic exercise training outcomes in COPD.

Covey MK, Collins EG, Reynertson SI, Dilling DF.

Respir Med. 2014 Aug;108(8):1141-52. doi: 10.1016/j.rmed.2014.06.001. Epub 2014 Jun 11.

18.

Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosis.

Gilbert ER, Eby JM, Hammer AM, Klarquist J, Christensen DG, Barfuss AJ, Boissy RE, Picken MM, Love RB, Dilling DF, Le Poole IC.

Am J Pathol. 2013 Jul;183(1):226-34. doi: 10.1016/j.ajpath.2013.04.002. Epub 2013 May 10. Erratum in: Am J Pathol. 2013 Nov;183(5):1698.

PMID:
23665200
19.

A current viewpoint of lymphangioleiomyomatosis supporting immunotherapeutic treatment options.

Dilling DF, Gilbert ER, Picken MM, Eby JM, Love RB, Le Poole IC.

Am J Respir Cell Mol Biol. 2012 Jan;46(1):1-5. doi: 10.1165/rcmb.2011-0215TR. Review.

PMID:
21940815
20.

Advances in lung transplantation: the year in review.

Dilling DF, Glanville AR.

J Heart Lung Transplant. 2011 Mar;30(3):247-51. doi: 10.1016/j.healun.2010.12.005. Epub 2011 Jan 6. Review.

PMID:
21211995
21.

Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells.

Klarquist J, Barfuss A, Kandala S, Reust MJ, Braun RK, Hu J, Dilling DF, McKee MD, Boissy RE, Love RB, Nishimura MI, Le Poole IC.

Am J Pathol. 2009 Dec;175(6):2463-72. doi: 10.2353/ajpath.2009.090525. Epub 2009 Nov 5.

Supplemental Content

Loading ...
Support Center